Efficacy and safety of ongericimab in Chinese statin-intolerant patients with primary hypercholesterolemia or mixed dyslipidemia: a randomized, placebo-controlled phase 3 trial
1. 系统已在2026-05-29 11:12:52对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/j.atherosclerosis.2025.120408
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S0021915025013061
其他信息:
出版社: Elsevier BV
作者: Chunli Shao; Shu Zhang; Zhifeng Cheng; Keping Yang; Gaopin Wang; Xiaoxia Shi; Haibo Yang; Yuan Ji; Hua Li; Shanchun Zhang; Jinxia Ma; Zhaohui Pei; Yumin Zhang; Yang Li; Lipeng Li; Yang Zheng; Cong Shao; Mengqi Zhang; Yu Hao; Yi-da Tang

